Wastewater surveillance has become an important part of South Africa’s COVID-19 monitoring systems and might even help to give early warning of a potential third wave of infections. Tiyese Jeranji looks at what is involved.
Like with SARS-CoV2, we need to rapidly implement and scale-up effective tuberculosis (TB) prevention interventions, while remaining adaptive to prevailing needs across the country. If we choose to pursue this more deliberate approach to TB prevention in South Africa, World TB Day will no longer be an admission of insufficient progress, but a celebration of defeating our long-standing battle with this curable disease, writes Dr Kavindhran Velen and Professor Salome Charalambous.
Reproductive health experts say South Africa recorded a 30% increase in maternal deaths during lockdown compared to the same period in 2019. Suicide, a previously unrecognised cause of maternal mortality in the country, also increased and some experts believe the stressors of the COVID-19 pandemic played a role. Tiyese Jeranji reports.
Gift of the Givers founder Dr Imtiaz Sooliman has declined social media calls that he be nominated for the 2021 Nobel Peace Prize. Bienne Huisman spoke to Sooliman about the organisation’s work during the pandemic, his background, and what keeps him going.
It has been over a year since the world saw the first confirmed case of COVID-19, yet the science behind the virus’ physical impact on children remains relatively unclear. Kathryn Cleary spoke to two experts in paediatrics and immunology to get an update on what we have learnt so far.
South Africa has struggled to secure adequate stock of urgently needed COVID-19 vaccines. This has raised questions about the state of the country’s local vaccine manufacturing capacity and why, after almost two decades of government support, South Africa’s partially state-owned vaccine manufacturer Biovac is not better positioned to respond to the pandemic. Catherine Tomlinson investigates.
While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.
The head of the South African arm of a key COVID-19 vaccine clinical trial is “full of pride” for the teams’ part in the research which has shown the vaccine candidate to be more than 90% effective according to early findings released this week. It however remains unclear whether the vaccine will be available in South Africa once registered. Adele Baleta reports.
How many people have actually died of COVID-19 in South Africa and what do we know about the possibility of a second wave? As the first, and hopefully the only, substantial wave of infections and death recedes, Spotlight Editor Marcus Low assesses the many remaining uncertainties.
Initial results from an antibody survey conducted in the Cape Town Metro indicate that of 2 700 pregnant women and people living with HIV making use of the public healthcare system, 40% have previously been infected with SARS-CoV-2. Adele Baleta has the details.